EFFECT OF UPADACITINIB ON EXTRAINTESTINAL MANIFESTATIONS IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE

Jean-Frédéric Colombel  1     David P. Hudesman  2     Qian Cao  3     Subrata Ghosh  4     Walter Reinisch  5     Ana Paula Machado De Lacerda  6     Elena Dubcenco  6     Chirag Doshi  6     Samuel Anyanwu  6     Tian Feng  6    
1 Icahn School of Medicine at Mount Sinai, New York, United States
2 NYU Langone Health, New York, NY, United States
3 Sin Run Shaw Hospital, College of Medicine Zhejiang University, Hanzhou, China
4 University College Cork, Cork, Ireland
5 Medical University of Vienna, Vienna, Austria
6 AbbVie Inc., North Chicago, United States

Topic
IBD

Session
Meet the giants at the poster (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing